3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Conditions
Prostatic Neoplasms
35
Motor Activity
25
Breast Neoplasms
5
Urinary Bladder Neoplasms
4
Colorectal Neoplasms
4
Neoplasms
3
Fatigue
3
Carcinoma, Renal Cell
3
Ovarian Neoplasms
2
Obesity
2
Kidney Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Smoking
1
Sleep Initiation and Maintenance Disorders
1
Risk Reduction Behavior
1
Prostatectomy
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Patient Preference
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Metabolic Syndrome
1
Mesothelioma, Malignant
1
Malnutrition
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Insulin Resistance
1
Hypoxia
1
Interventions
Nutrition Assessment
2
tocilizumab
1
Tirzepatide
1
Testosterone
1
Standard of Care
1
Specimen Handling
1
Resistance Training
1
Practice Guidelines as Topic
1
Pioglitazone
1
Palliative Care
1
Metformin
1
Lysine Acetyltransferase 5
1
Immunoglobulin G
1
Gonadotropin-Releasing Hormone
1
Exercise
1
Disulfides
1
Diet, Carbohydrate-Restricted
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus
×
Exercise
×
Genitourinary
×
Clear all
NCT02716623
2019-07-15
DEAL
University of Kansas Medical Center
Phase NA
Completed
5 enrolled